Dermatology Zone

Time Title
09:30 - 10:30 Atopic eczema: a patient journey from 0-18 years– evidence-based management for primary care
10:50 - 11:50 Dermatology and women’s health: managing acne and vulval conditions
12:10 - 13:10 Nurse, what is the matter with my skin? Common skin lesions and rashes seen in primary care – interactive quiz format
14:10 - 15:10 Psoriasis and psoriatic arthritis - evidence based management and guidelines
15:30 - 16:30 Dermatology update for nurse prescribers: What to prescribe for common skin conditions according to UK guidelines
16:30 Close of conference

Julie Van Onselen
Dermatology Education Partnership Ltd

Bio: Julie is a dermatology adviser and educator, Director of Dermatology Education Partnership (DEP) Ltd (www.dermatologyeducation.co.uk) , which focuses on dermatology educational projects and independent training. She has a clinical background in dermatology nursing and is a medical writer and past editor of the BDNG journal, Dermatological Nursing. She also works as a clinical adviser for skin care charities. Julie is passionate about improving dermatology care and support for people with skin conditions through developing educational initiatives for both healthcare professionals and people with skin conditions.

Abstract: The dermatology zone at EXPO 2018 in London will focus on skin conditions, which are common in primary care. The atopic eczema session will focus on focusing on evidence based managing in atopic eczema from diagnosis in an infant, throughout childhood to young adulthood, this session will be particularly useful for health visitors and school nurses. Next, a focus on women’s health and dermatology, which will be useful for practice, nurses, in cervical screening and contraceptive roles. The skin lesion and rashes session will be an interactive quiz format, designed to help anyone in primary care recognise when to worry and when to reassure. The dermatology update for nurse prsescribers will update and build on current prescribing knowledge, looking at treatments options according to UK guidance.